作者：
Ballen,K. [1]
;
Mendizabal,A.M. [2]
;
Cutler,C. [3]
;
Politikos,I. [4]
;
Jamieson,K. [5]
;
Shpall,E.J. [6]
;
Dey,B.R. [7]
;
Attar,E. [8]
;
McAfee,S. [9]
;
Delaney,C. [10]
;
McCarthy,P. [11]
;
Ball,E.D. ;
Kamble,R. ;
Avigan,D. ;
Maziarz,R.T. ;
Ho,V.T. ;
Koreth,J. ;
Alyea,E. ;
Soiffer,R. ;
Wingard,J.R. ;
Boussiotis,V. ;
Spitzer,T.R. ;
Antin,J.H.
作者单位：
Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, United States
[1]
University of Florida Cancer Center, Gainsville, FL, United States
[2]
Knight Cancer Center, Oregon Health and Science University, Portland, OR, United States
[3]
Baylor College of Medicine, Houston, TX, United States
[4]
M.D. Anderson Cancer Center, Houston, TX, United States
[5]
Hematology/Oncology Division, Department of Medicine, Massachusetts General Hospital, Boston, MA
[6]
Roswell Park Cancer Institute, Buffalo,NY, United States
[7]
Beth Israel Deaconess Medical Center, Boston, MA, United States
[8]
The EMMES Corporation, Rockville, MD, United States
[9]
University of California at San Diego, La Jolla, CA, United States
[10]
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
[11]
发布时间
2013-11-20
换一批
